Human herpesvirus-6 as an inducer of porphyria cutanea tarda: Implications from a case

Transplant Infectious Disease

Volumn 12, Issue 5, 2010, Pages 432-436

  Weber, T ^a   Theurich, S ^a   Christopeit, M ^a   Klapperstueck, T ^a   Behre, G ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Allogeneic transplantation; Hepatitis; HHV6; Porphyria cutanea tarda

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MYCOPHENOLIC ACID; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; HEME SYNTHESIS; HEPATITIS; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; IRON OVERLOAD; MALE; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REACTIVATION; WHOLE BODY RADIATION;

DNA, VIRAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS, VIRAL, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; ROSEOLOVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650479425     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00511.x     Document Type: Article

References (16)

1. Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27 (4): 651-653.
2. Ward KN. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis 2005; 18 (3): 247-252.
3. Yoshikawa T. Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol 2004; 124 (4): 421-432.
4. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40 (7): 932-940.
5. Ljungman P, Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111 (3): 774-781.
6. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998; 18 (1): 67-75.
7. Bulaj ZJ, Phillips JD, Ajioka RS, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95 (5): 1565-1571.
8. Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol 2006; 135 (3): 281-292.
9. Locatelli G, Santoro F, Veglia F, Gobbi A, Lusso P, Malnati MS. Real-time quantitative PCR for human herpesvirus 6 DNA. J Clin Microbiol 2000; 38 (11): 4042-4048.
10. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J Gastroenterol 2007; 13 (35): 4699-4706.
11. Gorman N, Ross KL, Walton HS, et al. Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron. Hepatology 2002; 35 (4): 912-921.
12. Bulaj ZJ, Ajioka RS, Phillips JD, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000; 343 (21): 1529-1535.
13. Smith AG, Francis JE. Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload. Biochem J 1987; 246 (1): 221-226.
14. Mori Y. Recent topics related to human herpesvirus 6 cell tropism. Cell Microbiol 2009; 11 (7): 1001-1006.
15. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis 2002; 185 (1): 110-113.
16. Chevret L, Boutolleau D, Halimi-Idri N, et al. Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure. J Med Virol 2008; 80 (6): 1051-1057.